Top

Published in:

01-03-2018 | Translational Neurosciences - Review Article

Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states

Authors: Véronique Sgambato-Faure, Léon Tremblay

Published in: Journal of Neural Transmission | Issue 3/2018

Abstract

Thanks to the non-human primate (NHP), we have shown that the pharmacological disturbance of the anterior striatum or of external globus pallidus triggers a set of motivation and movement disorders, depending on the functional subterritory involved. One can, therefore, assume that the aberrant activity of the different subterritories of basal ganglia (BG) could lead to different behavioral disorders in neuropsychiatric disorders as Tourette’s syndrome and Parkinson’s disease. We are now addressing in the NHP the impact of modulating dopamine or serotonin within the BG on behavioral disorders. Indeed, we have shown a prominent role of serotonergic degeneration within the ventral striatum and caudate nucleus in neuropsychiatric symptoms in de novo PD patients. Of note, the serotonergic modulation of these BG regions in the NHP plays also a critical role in the induction or treatment of behavioral disorders. Given that both dopamine and serotonin are targeted to treat neuropsychiatric disorders, we are studying the effects of modulating dopamine and serotonin transporters in the different territories of the striatum, and more particularly within the ventral striatum on decision-making processing at both behavioral and neuronal levels. Finally, we evidence the need to extend the pharmacological approach to the receptors of these two neuromodulator systems as the use of substances targeting receptor subtypes preferentially localized in the associative and limbic territories of BG could be very effective to specifically improve the behavioral disorders in Parkinson’s disease, Gilles de la Tourette syndrome but also in several psychiatric disorders such as depression, anxiety, anorexia, or impulse control disorders.

Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266–271PubMedCrossRef

Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381PubMedCrossRef

Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res 85:119–146PubMedCrossRef

Arnt J, Olsen CK (2011) 5-HT₆ receptor ligands and their antipsychotic potential. Int Rev Neurobiol 96:141–161PubMedCrossRef

Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis CA, Wagner A, Thornton L, Hoge J, Ziolko SK, Becker CR, McConaha CW, Kaye WH (2007) Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61(9):1090–1099PubMedCrossRef

Baizer JS, Desimone R, Ungerleider LG (1993) Comparison of subcortical connections of inferior temporal and posterior parietal cortex in monkeys. Vis Neurosci 10:59–72PubMedCrossRef

Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP (2010) Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 67:416–421PubMedCrossRef

Ballanger B, Beaudoin-Gobert M, Neumane S, Epinat J, Metereau E, Duperrier S, Broussolle E, Thobois S, Bonnefoi F, Tourvielle C, Lavenne F, Costes N, Lebars D, Zimmer L, Sgambato-Faure V, Tremblay L (2016) Imaging dopamine and serotonin systems on MPTP Monkeys: a longitudinal PET investigation of compensatory mechanisms. J Neurosci 36(5):1577–1589PubMedCrossRef

Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O (2010) miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 329(5998):1537–1541PubMedCrossRef

Baup N, Grabli D, Karachi C, Mounayar S, François C, Yelnik J, Féger J, Tremblay L (2008) High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 28(35):8785–8788PubMedCrossRef

BBC (2001) Ecstasy & Agony. http://www.bbc.co.uk/science/horizon/2000/ecstasyagony.shtml

Beaudoin-Gobert M, Epinat J, Météreau E, Duperrier S, Neumane S, Ballanger B, Lavenne F, Liger F, Tourvielle C, Bonnefoi F, Costes N, Bars DL, Broussolle E, Thobois S, Tremblay L, Sgambato-Faure V (2015) Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. Brain 138(Pt 9):2632–2647PubMedCrossRef

Becerra L, Breiter HC, Wise R, Gonzalez RG, Borsook D (2001) Reward circuitry activation by noxious thermal stimuli. Neuron 32(5):927–946PubMedCrossRef

Becker G, Colomb J, Sgambato-Faure V, Tremblay L, Billard T, Zimmer L (2014) Preclinical evaluation of [¹⁸F]2FNQ1P as the first fluorinated serotonin 5-HT₆ radioligand for PET imaging. Eur J Nucl Med Mol Imaging 42:495–502PubMedCrossRef

Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML (2014) Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease. J Med Chem 57(17):7160–7181PubMedCrossRef

Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137–151PubMedCrossRef

Bezard E, Gross CE (1998) Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Prog Neurobiol 55:93–116PubMedCrossRef

Bishop C, Taylor JL, Kuhn DM, Eskow KL, Park JY, Walker PD (2006) MDMA and fenfluramine reduce l-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation. Eur J Neurosci 23:2669–2676PubMedCrossRef

Blomstedt P, Sjöberg RL, Hansson M, Bodlund O, Hariz MI (2013) Deep brain stimulation in the treatment of obsessive-compulsive disorder. World Neurosurg 80(6):e245–e253PubMedCrossRef

Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M (2013) The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction. 108(5):953–963PubMedCrossRef

Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M (2014) In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Mol Psychiatry 19(12):1305–1313PubMedCrossRef

Bray S, O’Doherty J (2007) Neural coding of reward-prediction error signals during classical conditioning with attractive faces. J Neurophysiol 97(4):3036–3045PubMedCrossRef

Bromberg-Martin ES, Hikosaka O, Nakamura K (2010) Coding of task reward value in the dorsal raphe nucleus. J Neurosci 30:6262–6272PubMedPubMedCentralCrossRef

Buoli M, Caldiroli A, Caletti E, Paoli RA, Altamura AC (2013) New approaches to the pharmacological management of generalized anxiety disorder. Expert Opin Pharmacother 14(2):175–184PubMedCrossRef

Caillé F, Morley TJ, Tavares AA, Papin C, Twardy NM, Alagille D, Lee HS, Baldwin RM, Seibyl JP, Barret O, Tamagnan GD (2013) Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699. Bioorg Med Chem Lett 23(23):6243–6247PubMedCrossRef

Camus SM, Blois-Heulin C, Li Q, Hausberger M, Bezard E (2013a) Behavioural profiles in captive-bred cynomolgus macaques: towards monkey models of mental disorders? PLoS ONE 8:e62141PubMedPubMedCentralCrossRef

Camus SM, Rochais C, Blois-Heulin C, Li Q, Hausberger M, Bezard E (2013b) Birth origin differentially affects depressive-like behaviours: are captive-born cynomolgus monkeys more vulnerable to depression than their wild-born counterparts? PLoS ONE 8(7):e67711PubMedPubMedCentralCrossRef

Carta M, Tronci E (2014) Serotonin system implication in l-DOPA-induced dyskinesia: from animal models to clinical investigations. Front Neurol 5:78PubMedPubMedCentralCrossRef

Caruana F, Jezzini A, Sbriscia-Fioretti B, Rizzolatti G, Gallese V (2011) Emotional and social behaviors elicited by electrical stimulation of the insula in the macaque monkey. Curr Biol 21(3):195–199PubMedCrossRef

Casper RC (1998) Depression and eating disorders. Depress. Anxiety 8(Suppl. 1):96e104

Casper RC (2006) The “drive for activity” and “restlessness” in anorexia nervosa: potential pathways. J Affect Disord 92:99e107CrossRef

Catenoix H, Isnard J, Guénot M, Petit J, Remy C, Mauguière F (2008) The role of the anterior insular cortex in ictal vomiting: a stereotactic electroencephalography study. Epilepsy Behav 13(3):560–563PubMedCrossRef

Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474PubMedCrossRef

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665):746–758PubMedCrossRef

Colomb J, Becker G, Fieux S, Zimmer L, Billard T (2014) Syntheses, Radiolabeling, and in vitro evaluations of fluorinated PET radioligands of 5-HT₆ serotoninergic receptors. J Med Chem 57:3884–3890PubMedCrossRef

Compan V, Zhou M, Grailhe R, Gazzara RA, Martin R, Gingrich J, Dumuis A, Brunner D, Bockaert J, Hen R (2004) Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knockout mice. J Neurosci 24(2):412–419PubMedCrossRef

Conti MM, Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Dell’isola R, Katzman AC, Bishop C (2014) Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats. Neuropharmacology 77:1–8PubMedCrossRef

Davis C (1997) Eating disorders and hyperactivity: a psychobiological perspective. Can J Psychiatry Rev Can Psychiatr 42:168–175CrossRef

Del Tredici K, Braak H (2012) Lewy pathology and neurodegeneration in premotor Parkinson’s disease. Mov Disord 27:597–607PubMedCrossRef

Delgado MR, Jou RL, LeDoux JE, Phelps EA (2009) Avoiding negative outcomes: tracking the mechanisms of avoidance learning in humans during fear conditioning. Front Behav Neurosci 3:33PubMedPubMedCentralCrossRef

Ernst M, Nelson EE, McClure EB, Monk CS, Munson S, Eshel N, Zarahn E, Leibenluft E, Zametkin A, Towbin K, Blair J, Charney D, Pine DS (2004) Choice selection and reward anticipation: an fMRI study. Neuropsychologia 42(12):1585–1597PubMedCrossRef

Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E (2010) Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 35(3):591–604PubMedCrossRef

Flaherty AW, Graybiel AM (1991) Corticostriatal transformations in the primate somatosensory system. Projections from physiologically mapped body-part representations. J Neurophysiol 66:1249–1263PubMedCrossRef

Fontenot MB, Musso MW, McFatter RM, Anderson GM (2009) Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci 48:176–184PubMedPubMedCentral

Galineau L, Kas A, Worbe Y, Chaigneau M, Herard A-S, Guillermier S, Delzescaux T, Féger J, Hantraye P, Tremblay L (2016) Cortical areas involved in behavioral expression of external pallidum dysfunctions: A PET imaging study in non-human primates. Neuroimage (in press)

Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B (1991) Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson’s disease. Ann Neurol 30:365–374PubMedCrossRef

Gerardin E, Pochon JB, Poline JB, Tremblay L, Van de Moortele PF, Levy R, Dubois B, Le Bihan D, Lehéricy S (2004) Distinct striatal regions support movement selection, preparation and execution. NeuroReport 15(15):2327–2331PubMedCrossRef

Gilman S, Koeppe RA, Nan B, Wang CN, Wang X, Junck L, Chervin RD, Consens F, Bhaumik A (2010) Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 74(18):1416–1423PubMedPubMedCentralCrossRef

Godart NT, Flament MF, Lecrubier Y, Jeammet P (2000) Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance. Eur Psychiatry 15:38–45PubMedCrossRef

Grabli D, McCairn K, Hirsch EC, Agid Y, Féger J, François C, Tremblay L (2004) Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain 127:2039–2054PubMedCrossRef

Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S (2008) Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans. Hum Brain Mapp 29(4):400–410PubMedCrossRef

Graybiel AM (2005) The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15:638–644PubMedCrossRef

Gregorios-Pippas L, Tobler PN, Schultz W (2009) Short-term temporal discounting of reward value in human ventral striatum. J Neurophysiol 101:1507–1523PubMedPubMedCentralCrossRef

Grupe DW, Nitschke JB (2013) Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci 14(7):488–501PubMedPubMedCentralCrossRef

Haahr ME, Rasmussen PM, Madsen K, Marner L, Ratner C, Gillings N, Baaré WF, Knudsen GM (2012) Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry. Neuroimage 61(4):884–888PubMedCrossRef

Haahr ME, Fisher PM, Jensen CG, Frokjaer VG, Mahon BM, Madsen K, Baaré WF, Lehel S, Norremolle A, Rabiner EA, Knudsen GM (2014) Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study. Mol Psychiatry 19(4):427–432PubMedCrossRef

Haber SN (2003) The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26(4):317–330PubMedCrossRef

Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35(1):4–26PubMedCrossRef

Heal D, Gosden J, Smith S (2011) The 5-HT₆ receptor as a target for developing novel antiobesity drugs. Int Rev Neurobiol 96:73–109PubMedCrossRef

Heller AS, Johnstone T, Light SN, Peterson MJ, Kolden GG, Kalin NH, Davidson RJ (2013) Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. Am J Psychiatry 170:197–206PubMedPubMedCentralCrossRef

Hinton EC, Parkinson JA, Holland AJ, Arana FS, Roberts AC, Owen AM (2004) Neural contributions to the motivational control of appetite in humans. Eur J Neurosci 20(5):1411–1418PubMedCrossRef

Hollerman JR, Tremblay L, Schultz W (1998) Influence of reward expectation on behavior-related neuronal activity in primate striatum. J Neurophysiol 80(2):947–963PubMedCrossRef

Holtkamp K, Konrad K, Kaiser N, Ploenes Y, Heussen N, Grzella I, Herpertz-Dahlmann B (2005) A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy. J Psychiatr Res 39:303–310PubMedCrossRef

Huot P, Johnston TH, Darr T, Hazrati L-N, Visanji NP, Pires D, Brotchie JM, Fox SH (2010) Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations. Mov Disord 25:1399–1408PubMedCrossRef

Huot P, Fox SH, Brotchie JM (2011a) The serotonergic system in Parkinson’s disease. Prog Neurobiol 95:163–212PubMedCrossRef

Huot P, Johnston TH, Lewis KD, Koprich JB, Reyes MG, Fox SH, Piggott MJ, Brotchie JM (2011b) Characterization of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in vitro and in the MPTP-lesioned primate: R-MDMA reduces severity of dyskinesia, whereas S-MDMA extends duration of ON-time. J Neurosci 3:7190–7198CrossRef

Imbert C, Bezard E, Guitraud S, Boraud T, Gross CE (2000) Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Methods 96:71–76PubMedCrossRef

Iravani MM, Jackson MJ, Kuoppamäki M, Smith LA, Jenner P (2003) 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. J Neurosci 23:9107–9115PubMed

Ismail Z, Herrmann N, Rothenburg LS, Cotter A, Leibovitch FS, Rafi-Tari S, Black SE, Lanctôt KL (2004) A functional neuroimaging study of appetite loss in Alzheimer’s disease. J Neurol Sci 271:97–103CrossRef

Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V (2007) Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proc Natl Acad Sci USA. 104(41):16335–16340PubMedPubMedCentralCrossRef

Jean A, Laurent L, Bockaert J, Charnay Y, Dusticier N, Nieoullon A, Barrot M, Neve R, Compan V (2012) The nucleus accumbens 5-HTR₄-CART pathway ties anorexia to hyperactivity. Transl Psychiatry 2(12):e203PubMedPubMedCentralCrossRef

Jellinger KA (1999) Post mortem studies in Parkinson’s disease—Is it possible to detect brain areas or specific symptoms? J Neural Transm 56:1–29CrossRef

Jensen J, McIntosh AR, Crawley AP, Mikulis DJ, Remington G, Kapur S (2003) Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40:1251–1257PubMedCrossRef

Jezzini A, Caruana F, Stoianov I, Gallese V, Rizzolatti G (2012) Functional organization of the insula and inner perisylvian regions. Proc Natl Acad Sci USA. 109(25):10077–10082PubMedPubMedCentralCrossRef

Kalin NH, Shelton SE, Fox AS, Oakes TR, Davidson RJ (2005) Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry 58(10):796–804PubMedPubMedCentralCrossRef

Kaye WH, Nagata T, Weltzin TE, Hsu LG, Sokol MS, McConaha C, Plotnicov KH, Weise J, Deep D (2001) Double-blind placebo-controlled administration of fluoxetine in restricting-and restricting-purging-type anorexia nervosa. Biol Psychiatry 49:644–652PubMedCrossRef

Kaye WH, Fudge JL, Paulus M (2009) New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 10(8):573–584PubMedCrossRef

Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N Engl J Med 318(14):876–880PubMedCrossRef

Knutson B, Fong GW, Adams CM, Varner JL, Hommer D (2001) Dissociation of reward anticipation and outcome with event-related fMRI. NeuroReport 12(17):3683–3687PubMedCrossRef

Lavoie B, Parent A (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol 99(1):1–16CrossRef

Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson’s disease. Mov Disord 24(12):1803–1810PubMedCrossRef

Lehéricy S, Bardinet E, Tremblay L, Van de Moortele PF, Pochon JB, Dormont D, Kim DS, Yelnik J, Ugurbil K (2006) Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb Cortex 16(2):149–161PubMedCrossRef

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382(9896):951–962PubMedCrossRef

Loane C, Wu K, Bain P, Brooks DJ, Piccini P, Politis M (2013) Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD. Neurology 80:1850–1855PubMedPubMedCentralCrossRef

Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S (2016) The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease. Brain 139(Pt 9):2486–2502PubMedCrossRef

Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chéreau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardès S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Vérin M, Houeto JL, Pollak P, Benabid AL, Agid Y, Krack P, Millet B, Pelissolo A, STOC Study Group (2008) Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 359(20):2121–2134PubMedCrossRef

Marinus J, Visser M, Verwey NA, Verhey FR, Middelkoop HA, Stiggelbout AM, van Hilten JJ (2003) Assessment of cognition in Parkinson’s disease. Neurology 61(9):1222–1228PubMedCrossRef

Matsumura M, Tremblay L, Richard H, Filion M (1995) Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 65(1):59–70PubMedCrossRef

Mazzucchi S, Frosini D, Ripoli A, Nicoletti V, Linsalata G, Bonuccelli U, Ceravolo R (2015) Serotonergic antidepressant drugs and l-DOPA-induced dyskinesias in Parkinson’s disease. Acta Neurol Scand 131(3):191–195PubMedCrossRef

McCabe C, Mishor Z, Cowen PJ, Harmer CJ (2010) Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry 67:439–445PubMedPubMedCentralCrossRef

Meneses A (2014) Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative. Rev Neurosci 25(3):325–356PubMed

Middleton FA, Strick PL (1996) The temporal lobe is a target of output from the basal ganglia. Proc Natl Acad Sci USA 93:8683–8687PubMedPubMedCentralCrossRef

Middleton FA, Strick PL (2000) Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 42(2):183–200PubMedCrossRef

Moore TJ, Glenmullen J, Mattison DR (2014) Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 174(12):1930–1933PubMedCrossRef

Morissette M, Goulet M, Grondin R, Blanchet P, Bédard PJ, Di Paolo T, Lévesque D (1998) Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Eur J Neurosci 10(8):2565–2573PubMedCrossRef

Mounayar S, Boulet S, Tandé D, Jan C, Pessiglione M, Hirsch EC, Féger J, Savasta M, François C, Tremblay L (2007) A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain 130(Pt 11):2898–2914PubMedCrossRef

Murrough JW, Henry S, Hu J, Gallezot JD, Planeta-Wilson B, Neumaier JF, Neumeister A (2011) Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology 213(2–3):547–553PubMedCrossRef

Napadow V, Sheehan JD, Kim J, Lacount LT, Park K, Kaptchuk TJ, Rosen BR, Kuo B (2013) The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex 23(4):806–813PubMedCrossRef

Neumane S, Mounayar S, Jan C, Epinat J, Ballanger B, Costes N, Féger J, Thobois S, François C, Sgambato-Faure V, Tremblay L (2012) Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys. Neurobiol Dis 48(1):27–39PubMedCrossRef

Nichols DE, Nichols CD (2008) Serotonin receptors. Chem Rev 108(5):1614–1641PubMedCrossRef

O’Doherty JP, Deichmann R, Critchley HD, Dolan RJ (2002) Neural responses during anticipation of a primary taste reward. Neuron 33(5):815–826PubMedCrossRef

O’Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, Djamshidian A, Lees AJ, Piccini P (2011) Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive-compulsive behaviours. Brain 134:969–978PubMedCrossRef

Obeso JA, Olanow CW, Nutt JG (2000) Levodopa motor complications in Parkinson’s disease. Trends Neurosci 23:S2–S7PubMedCrossRef

Parent A, Mackey A, De Bellefeuille L (1983) The subcortical afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study. Neuroscience 10(4):1137–1150PubMedCrossRef

Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50(6):743–755PubMedCrossRef

Pavese N, Simpson BS, Metta V, Ramlackhansingh A, Chaudhuri KR, Brooks DJ (2012) [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [11C]DASB PET study in Parkinson’s disease. Neuroimage 59(2):1080–1084PubMedCrossRef

Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I (2015) [11C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson’s disease with impulse control disorders. Mov Disord 30(2):160–166PubMedCrossRef

Pessiglione M, Guehl D, Agid Y, Hirsch EC, Féger J, Tremblay L (2003) Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson’s disease. Brain 126:1392–1408PubMedCrossRef

Pessiglione M, Guehl D, Jan C, François C, Hirsch EC, Féger J, Tremblay L (2004) Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference. Eur J Neurosci 19:437–446PubMedCrossRef

Pifl C, Schingnitz G, Hornykiewicz O (1991) Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 44(3):591–605PubMedCrossRef

Pine A, Shiner T, Seymour B, Dolan RJ (2010) Dopamine, time, and impulsivity in humans. J Neurosci 30:8888–8896PubMedPubMedCentralCrossRef

Politis M (2014) Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 10:708–722PubMedCrossRef

Politis M, Niccolini F (2015) Serotonin in Parkinson’s disease. Behav Brain Res 277:136–145PubMedCrossRef

Politis M, Loane C, Wu K, O’Sullivan SS, Woodhead Z, Kiferle L, Lawrence AD, Lees AJ, Piccini P (2013) Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease. Brain 136(2):400–411PubMedCrossRef

Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE et al (2014) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients. J Clin Invest 124:1340–1349PubMedPubMedCentralCrossRef

Ponseti J, Bosinski HA, Wolff S, Peller M, Jansen O, Mehdorn HM, Büchel C, Siebner HR (2006) A functional endophenotype for sexual orientation in humans. Neuroimage 33(3):825–833PubMedCrossRef

Porras G, Li Q, Bezard E (2012) Modeling Parkinson’s disease in primates: the MPTP model. Cold Spring Harb Perspect Med 2:a009308PubMedPubMedCentralCrossRef

Pringle A, Jennings KA, Line S, Bannerman DM, Higgs S, Sharp T (2008) Mice overexpressing the 5- hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine. Psychopharmacology 200(2):291–300PubMedCrossRef

Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D (2010) Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 67(7):701–711PubMedCrossRef

Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128(Pt 6):1314–1322PubMedCrossRef

Ricaurte GA, Yuan J, McCann UD (2000) (+/-)3,4-Methylenedioxymethamphetamine (’Ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5–10PubMedCrossRef

Romo RE, Scarnati E, Schultz W (1992) Role of primate basal ganglia and frontal cortex in the internal generation of movements. II. Movement-related activity in the anterior striatum. Exp Brain Res 91(3):385–395PubMedCrossRef

Rylander D, Parent M, O’Sullivan SS, Dovero S, Lees AJ, Bézard E, Cenci MA (2010) Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 68:619–628PubMedCrossRef

Saga Y, Tremblay L (2016) Ventral Striatopallidal pathways involved in appetitive and aversive motivational processes. In: Dreher JC, Tremblay L (eds) Decision neuroscience. An integrative perspective, pp 47–58

Saga Y, Richard A, Sgambato-Faure V, Hoshi E, Tobler PN, Tremblay L. (2016) Ventral pallidum encodes contextual information and controls aversive behaviors. Cereb Cortex [pii: bhw107]

Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson’s disease. Brain Res 275(2):321–328PubMedCrossRef

Schatzberg AF, Nemeroff CB (2009) The American Psychiatric Publishing Textbook of Psychopharmacology, 4th edn. American Psychiatric Publishing Inc, Arlington

Schoenbaum G, Setlow B, Ramus SJ (2003) A systems approach to orbitofrontal cortex function: recordings in rat orbitofrontal cortex reveal interactions with different learning systems. Behav Brain Res 146(1–2):19–29PubMedCrossRef

Schultz W, Romo R (1992) Role of primate basal ganglia and frontal cortex in the internal generation of movements. I. Preparatory activity in the anterior striatum. Exp Brain Res 91(3):363–384PubMedCrossRef

Schultz W, Apicella P, Scarnati E, Ljungberg T (1992) Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 12(12):4595–4610PubMed

Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593–1599PubMedCrossRef

Schultz W, Tremblay L, Hollerman JR (1998) Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37:421–429PubMedCrossRef

Seeman P (2015) Parkinson’s disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse 69(4):183–189PubMedCrossRef

Sgambato-Faure V, Worbe Y, Epinat J, Féger J, Tremblay L (2016) Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates. Brain Struct Funct. 221(1):345–364PubMedCrossRef

St Onge JR, Floresco SB (2009) Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 34:681–697PubMedCrossRef

Stark P, Hardison CD (1985) A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 46:53–58PubMed

Stefano GB, Ptáček R, Kuželová H, Mantione KJ, Raboch J, Papezova H, Kream RM (2013) Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders. Med Sci Monit 19:353–358PubMedPubMedCentralCrossRef

Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA (2002) Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med 43:678–692PubMedPubMedCentral

Tanaka SC, Schweighofer N, Asahi S, Shishida K, Okamoto Y, Yamawaki S, Doya K (2007) Serotonin differentially regulates short- and long-term prediction of rewards in the ventral and dorsal striatum. PLoS One 2(12):e1333PubMedPubMedCentralCrossRef

Tavares AA, Caillé F, Barret O, Papin C, Lee H, Morley TJ, Fowles K, Holden D, Seibyl JP, Alagille D, Tamagnan GD (2014) In vivo evaluation of 18F-MNI698: an 18F-labeled radiotracer for imaging of serotonin 4 receptors in brain. J Nucl Med 55:858–864PubMedCrossRef

Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P (2010) Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain 133(Pt 4):1111–1127PubMedCrossRef

Thobois S, Lhommée E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V, Pelissier P, Chabardes S, Mertens P, Quesada JL, Bosson JL, Pollak P, Broussolle E, Krack P (2013) Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 136(5):1568–1577PubMedCrossRef

Tobler PN, Fiorillo CD, Schultz W (2005) Adaptive coding of reward value by dopamine neurons. Science 307:1642–1645PubMedCrossRef

Tom SM, Fox CR, Trepel C, Poldrack RA (2007) The neural basis of loss aversion in decision-making under risk. Science 315(5811):515–518PubMedCrossRef

Tomasi D, Volkow ND (2013) Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit Rev Biochem Mol Biol 48(1):1–19PubMedCrossRef

Tremblay L, Worbe Y, Hollerman R (2009) The ventral striatum: a heterogeneous structure involved in reward processing, motivation and decision-making. In: Dreher JC, Tremblay L (eds) Handbook of Reward and Decision Making. Academic Press, Oxford, pp 51–77CrossRef

Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Féger J (2015) Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord 30(9):1155–1170PubMedCrossRef

Varnäs K, Nyberg S, Karlsson P, Pierson ME, Kågedal M, Cselényi Z, McCarthy D, Xiao A, Zhang M, Halldin C, Farde L (2011) Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369. Psychopharmacology 213(2–3):533–545PubMedCrossRef

Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, Middelkoop HA, van Hilten JJ (2007) Cognitive impairment in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78(11):1182–1187PubMedPubMedCentralCrossRef

Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E (2009) Chronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8(12):1140–1149PubMedCrossRef

Voon V, Napier C, Frank M, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut P-O (2016) Impulse control disorders and dyskinesias in Parkinson’s disease: an update. Lancet Neurol (in press)

Walsh BT, Fairburn CG, Mickley D, Sysko R, Parides MK (2004) Treatment of bulimia nervosa in a primary care setting. Am J Psychiatry 161(3):556–561PubMedCrossRef

Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30(2):121–127PubMedCrossRef

Whone AL, Moore RY, Piccini PP, Brooks DJ (2003) Plasticity of the nigropallidal pathway in Parkinson’s disease. Ann Neurol 53(2):206–213PubMedCrossRef

Wicker B, Keysers C, Plailly J, Royet JP, Gallese V, Rizzolatti G (2003) Both of us disgusted in My insula: the common neural basis of seeing and feeling disgust. Neuron 40(3):655–664PubMedCrossRef

Woolley ML, Marsden CA, Fone KC (2004) 5-ht6 receptors. Curr Drug Targets CNS Neurol Disord 3(1):59–79PubMedCrossRef

Worbe Y, Baup N, Grabli D, Chaigneau M, Mounayar S, McCairn K, Féger J, Tremblay L (2009) Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cereb Cortex 19:1844–1856PubMedCrossRef

Worbe Y, Sgambato-Faure V, Epinat J, Chaigneau M, Tandé D, François C, Féger J, Tremblay L (2013) Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction. Cortex 49:1126–1140PubMedCrossRef

Yanagimoto K, Maeda H (2003) The nucleus accumbens unit activities related to the emotional significance of complex environmental stimuli in freely moving cats. Neurosci Res 46(2):183–189PubMedCrossRef

Zahodne LB, Fernandez HH (2008) Pathophysiology and treatment of psychosis in Parkinson’s disease: a review. Drugs Aging 25(8):665–682PubMedPubMedCentralCrossRef

Title: Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states
Authors: Véronique Sgambato-Faure
Léon Tremblay
Publication date: 01-03-2018
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 3/2018
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-017-1693-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

Reward and value coding by dopamine neurons in non-human primates

Progress in developing transgenic monkey model for Huntington’s disease

The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions

Dysregulation of striatal projection neurons in Parkinson’s disease

Non-human primate models of PD to test novel therapies